Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Grand Rapids › NPI 1619232204
Lab

Arcticax US LTD

Arcticax US LTD was paid $615K by Medicaid between Jan 2019 and Apr 2022, across 18 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 58% of everything it billed.

33Billing provider infoARCTICAX US LTD
GRAND RAPIDS, MI 49504
33aNPI1619232204assigned 07/10/2012
28Total paid$615K
24GClaims13,461
24DCodes billed18
24AFirst – last monthJan 2019 – Apr 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#54 of 108
Median peer was paid$588K
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20194,619$187K
20201,151$91K
20215,261$242K
20222,430$95K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 58% 5,235 3,244 $355K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 10% 3,023 2,217 $62K
81317 9.6% 456 220 $59K
81408 7.5% 474 221 $46K
81406 3.6% 425 221 $22K
81432 3.1% 489 221 $19K
81201 2.3% 434 221 $14K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.7% 584 552 $11K
81405 1.4% 493 221 $9K
81437 1.1% 108 81 $7K
81404 1.0% 492 221 $6K
81403 <1% 421 221 $3K
6 more codes
81407 <1% 148 $1K
81401 <1% 149 $400.04
81235 <1% 148 $256.67
81209 <1% 147 $58.97
81242 <1% 147 $54.93
81479 Unlisted molecular pathology procedure 0% 88 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHINES, GREGORY (PRESIDENT)
Parent organizationARCTICAX INC